Ann: Clinical Update on IHL-42X for Obstructive Sleep Apnoea, page-120

Looking at ATH.... Currently their MC is 38M with an SP of 3.5c.
@dalts66 said he held them for 3 years and then sold that spike obviously so he may have a better idea of what ATH was worth at the time which he bought.

During that spike, ATH went up to a high of 41c. That would give it a rough ~444M MC.

Off what exactly, FDA news? Was it even approval or something? I will need to double check. Yes it was for Parkinsons iirc which is a major disease.

Not sure how high ARDS could take us (assuming Stage 2 here and FDA news)

But OSA... A Phase 2B Human Trial. With FDA registration pathway. Which will likely get approval after results are out.

Market worth 10B, no pharma competitors. Only Resmed's CPAP machine which its users hate.

Err.... 52M MC atm. No comment.